AMR Action Fund CEO Henry Skinner and BIO CEO Dr. Michelle McMurry-Heath co-authored a Fortune op-ed on policy solutions to the AMR crisis.
The opinion piece discussed how proposed policies such as the PASTEUR Act and the DISARM Act can spur innovation and support biotechs developing urgently needed antibiotics. "We need a new model for the antibiotics market," they wrote. "We have the policy toolkit to address the challenge. It's on our leaders to execute." Read the full article here.